Results 201 to 210 of about 1,043,788 (265)

A Phase 1, Open-Label, Single-Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR Inhibitor. [PDF]

Clin Pharmacol Drug Dev
Zhu W, Hellemans P, Mitselos A, De Meulder M, Jiao JJ, Tian H.   +5 more
europepmc   +1 more source

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer. [PDF]

Curr Treat Options Oncol
Weiner-Gorzel K, McSorley L, Walshe JM.
europepmc   +1 more source

Recent Advances in the Management of IgA Nephropathy: From Supportive Care to Targeted Therapies. [PDF]

Cureus
Alroshodi A.
europepmc   +1 more source